Paris - Delayed Quote EUR

ATON (ALTAO.PA)

0.0088
+0.0003
+(3.53%)
As of 1:50:29 PM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Ms. Ayikoele Atayi General Manager 95k -- --

ATON

850 Boulevard Sébastien Brant
Illkirch-Graffenstaden
Strasbourg, 67400
France
33 9 72 56 94 99 https://www.aton-group.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Aton operates as a bioscience company in France. It engages in drug development preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company was founded in 1998 and is headquartered in Strasbourg, France.

Corporate Governance

ATON’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers